| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2010 | EP2199283A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient |
| 06/23/2010 | EP2199282A1 Amide compound |
| 06/23/2010 | EP2199280A1 Novel K04-0144 substances and process for production thereof |
| 06/23/2010 | EP2199275A1 Inhibitor of ischemic disorders |
| 06/23/2010 | EP2199274A1 Co-crystals of tramadol and paracetamol |
| 06/23/2010 | EP2198922A1 CNS chloride modulation and uses thereof |
| 06/23/2010 | EP2198891A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 06/23/2010 | EP2198889A1 Liquid pharmaceutical compositions comprising a triptan compound and Xylitol |
| 06/23/2010 | EP2198887A1 Therapeutic agent for leukoderma and method for acceleration of pigmentation |
| 06/23/2010 | EP2198879A1 CD74 modulator agent for regulating dendritic cell migration and device for studying the motility capacity of a cell |
| 06/23/2010 | EP2198872A1 Use of corrinoids for the treatment of skin diseases. |
| 06/23/2010 | EP2198871A1 Use of corrinoids for the treatment of skin diseases. |
| 06/23/2010 | EP2198870A1 Activator for blood coagulation factor vii promoter and utilization of the same |
| 06/23/2010 | EP2198869A1 Therapeutic or prophylactic agent for vasoconstriction |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP2198866A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 06/23/2010 | EP2198865A1 Nicotine-containing product |
| 06/23/2010 | EP2198864A1 Pharmaceutical compositions having an analgesic effect and containing 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides or related compounds |
| 06/23/2010 | EP2198863A1 Cancer treatment with gamma-secretase inhibitors |
| 06/23/2010 | EP2198862A1 Use of flavonoids to treat parasitic infection |
| 06/23/2010 | EP2198861A2 eNOS transcription enhancers for use in the cell therapy of ischemic heart diseases |
| 06/23/2010 | EP2198858A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 06/23/2010 | EP2198856A1 Process for preparing granular compositions |
| 06/23/2010 | EP2198854A2 Sustained-release liposomal anesthetic compositions |
| 06/23/2010 | EP2198723A1 Inflammation inhibiting compounds |
| 06/23/2010 | EP2198302A2 Sol-gel phase-reversible hydrogel templates and uses thereof |
| 06/23/2010 | EP2198029A1 Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 06/23/2010 | EP2198021A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 06/23/2010 | EP2197890A1 Mitochondrial compositions and uses thereof |
| 06/23/2010 | EP2197886A1 5-cyano-thienopyridines for the treatment of tumors |
| 06/23/2010 | EP2197885A1 Increasing the in vivo biological activity of biologically active compounds |
| 06/23/2010 | EP2197884A2 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 06/23/2010 | EP2197880A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 06/23/2010 | EP2197879A1 C7-substituted camptothecin analogs |
| 06/23/2010 | EP2197878A2 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases |
| 06/23/2010 | EP2197877A1 3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor |
| 06/23/2010 | EP2197876A1 Thiazole and oxazole kinase inhibitors |
| 06/23/2010 | EP2197875A1 Diacylglycerol acyltransferase inhibitors |
| 06/23/2010 | EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 06/23/2010 | EP2197873A1 Compounds and compositions as modulators of gpr119 activity |
| 06/23/2010 | EP2197872A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases |
| 06/23/2010 | EP2197860A1 New compounds as adenosine a1 receptor antagonists |
| 06/23/2010 | EP2197858A2 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same |
| 06/23/2010 | EP2197854A1 A new class of histone deacetylase inhibitors |
| 06/23/2010 | EP2197852A1 Spiro-condensed imidazolone derivatives inhibiting the glycine transporter |
| 06/23/2010 | EP2197851A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use |
| 06/23/2010 | EP2197850A1 Derivatives of n-phenylacetamide, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 06/23/2010 | EP2197849A1 N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators |
| 06/23/2010 | EP2197848A1 Novel r,r'-atracurium salts |
| 06/23/2010 | EP2197847A1 Deuterated 4 -oxoquinoline derivatives for the treatment of hiv infection |
| 06/23/2010 | EP2197846A1 Substituted 6-pheylnicotinic acids and the use thereof |
| 06/23/2010 | EP2197845A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
| 06/23/2010 | EP2197843A1 Piperidine derivatives as agonists of muscarinic receptors |
| 06/23/2010 | EP2197838A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 06/23/2010 | EP2197835A1 Bicyclic aryl and heteroaryl receptor modulators |
| 06/23/2010 | EP2197832A1 Novel aryl potassium channel blockers and uses thereof |
| 06/23/2010 | EP2197552A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 06/23/2010 | EP2197551A1 Soluble guanylate cyclase activators |
| 06/23/2010 | EP2197497A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 06/23/2010 | EP2197461A1 Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| 06/23/2010 | EP2197457A2 Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
| 06/23/2010 | EP2197455A2 Compositions and methods for the identification of inhibitors of retroviral infection |
| 06/23/2010 | EP2197454A1 Pharmaceutical compositions for administering oligonucleotides |
| 06/23/2010 | EP2197453A1 Azithromycin for treatment of skin disorders |
| 06/23/2010 | EP2197452A1 Dheas inhalation compositions |
| 06/23/2010 | EP2197451A1 2-amino-2,7-dideoxy-alpha-d-glycero-d-gluco-heptopyranosyl inhibitors of positive sense single-stranded rna envelope viruses |
| 06/23/2010 | EP2197450A1 7-keto dhea for psychiatric use |
| 06/23/2010 | EP2197449A2 Novel ophthalmic compositions |
| 06/23/2010 | EP2197448A1 Dosing regimen |
| 06/23/2010 | EP2197447A1 Antifungal agents |
| 06/23/2010 | EP2197445A2 Tsh receptor antagonizing tetrahydroquinoline compounds |
| 06/23/2010 | EP2197442A1 Polo-like kinase inhibitors |
| 06/23/2010 | EP2197441A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 06/23/2010 | EP2197438A1 Heterocyclic compounds as crth2 receptor antagonists |
| 06/23/2010 | EP2197437A1 Use of oleocanthal for the treatment of lipid metabolism disorders |
| 06/23/2010 | EP2197436A1 Preparation and a component intended to be added to a tobacco product |
| 06/23/2010 | EP2197435A1 Novel nutraceutical compositions containing thymol and/or p-cymene or plant extracts for cognition |
| 06/23/2010 | EP2197434A1 Resveratrol-containing compositions for modulating gene product concentration or activity |
| 06/23/2010 | EP2197432A1 Use of diazoxide for suppressing the plasma insulin level in a mammal |
| 06/23/2010 | EP2197431A1 Modulation of growth hormone, dhea, and cortisol with positive modulators of ampa type glutamate receptors |
| 06/23/2010 | EP2197430A2 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine |
| 06/23/2010 | EP2197428A1 Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
| 06/23/2010 | EP2197427A2 A multilayer pharmaceutical composition comprising an antagonist in a first layer and an agonist in a second layer |
| 06/23/2010 | EP2197426A2 Solid dispersion product containing n-aryl urea-based compound |
| 06/23/2010 | EP2197425A2 Solid dispersion product of n-aryl urea-based drugs |
| 06/23/2010 | EP2197424A2 Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof |
| 06/23/2010 | EP2197423A1 Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof |
| 06/23/2010 | EP2197420A1 Controlled release azithromycin solid dosages forms |
| 06/23/2010 | EP2197419A2 Medical devices and methods including polymers having biologically active agents therein |
| 06/23/2010 | EP2197416A1 Pharmaceutical formulation of valsartan |
| 06/23/2010 | EP2197415A1 Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone |
| 06/23/2010 | EP2197279A1 C10-substituted camptothecin analogs |
| 06/23/2010 | EP2197274A1 Azacytidine analogues and uses thereof |
| 06/23/2010 | EP2049477B1 Modulators of chemokine receptor activity, crystalline forms and process |
| 06/23/2010 | EP2024372B1 Thieno[3,2-d]pyrimidine derivative useful as pi3k inhibitor |
| 06/23/2010 | EP2024335B1 Novel imidazole derivatives, preparation and user thereof as medicine |
| 06/23/2010 | EP1910288B1 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 06/23/2010 | EP1885724B1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 06/23/2010 | EP1871181B1 Nutritional supplement for hiv patients |
| 06/23/2010 | EP1781276B1 Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain |